Northeast Financial Consultants’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.59M Sell
94,386
-1,965
-2% -$152K 0.31% 49
2025
Q1
$7.74M Hold
96,351
0.34% 49
2024
Q4
$7.89M Sell
96,351
-228
-0.2% -$19K 0.33% 46
2024
Q3
$7.97M Hold
96,579
0.35% 49
2024
Q2
$6.78M Sell
96,579
-1,100
-1% -$78.5K 0.31% 52
2024
Q1
$7.24M Sell
97,679
-1,572
-2% -$110K 0.36% 48
2023
Q4
$6.56M Hold
99,251
0.36% 49
2023
Q3
$6.24M Hold
99,251
0.39% 48
2023
Q2
$5.61M Sell
99,251
-5,080
-5% -$282K 0.34% 52
2023
Q1
$6.04M Sell
104,331
-19,891
-16% -$1.34M 0.39% 47
2022
Q4
$8.99M Sell
124,222
-3,037
-2% -$218K 0.61% 31
2022
Q3
$7.74M Hold
127,259
0.57% 30
2022
Q2
$7.99M Hold
127,259
0.56% 34
2022
Q1
$8.94M Hold
127,259
0.52% 38
2021
Q4
$7.95M Buy
127,259
+50,740
+66% +$3.18M 0.48% 41
2021
Q3
$4.73M Sell
76,519
-49,943
-39% -$3.01M 0.32% 53
2021
Q2
$7.57M Buy
126,462
+5,405
+4% +$343K 0.51% 39
2021
Q1
$7.36M Buy
121,057
+5,142
+4% +$284K 0.56% 35
2020
Q4
$5.44M Sell
115,915
-3,525
-3% -$153K 0.45% 39
2020
Q3
$4.44M Buy
119,440
+25,473
+27% +$967K 0.4% 41
2020
Q2
$3.43M Sell
93,967
-12,820
-12% -$446K 0.33% 46
2020
Q1
$3.26M Sell
106,787
-29,052
-21% -$1.29M 0.37% 48
2019
Q4
$6.92M Buy
135,839
+800
+0.6% +$38.6K 0.62% 38
2019
Q3
$6.37M Hold
135,039
0.65% 37
2019
Q2
$6.71M Sell
135,039
-2,400
-2% -$113K 0.69% 31
2019
Q1
$5.85M Hold
137,439
0.65% 32
2018
Q4
$5.64M Buy
137,439
+86,896
+172% +$3.73M 0.79% 28
2018
Q3
$2.36M Sell
50,543
-32,841
-39% -$1.5M 0.65% 32
2018
Q2
$3.63M Hold
83,384
1.12% 19
2018
Q1
$3.83M Hold
83,384
1.29% 18
2017
Q4
$4.22M Sell
83,384
-3,400
-4% -$179K 1.4% 15
2017
Q3
$4.51M Sell
86,784
-8,568
-9% -$417K 1.65% 12
2017
Q2
$4.67M Sell
95,352
-1,234
-1% -$57.2K 1.84% 10
2017
Q1
$4.55M Sell
96,586
-3,927
-4% -$187K 1.9% 7
2016
Q4
$4.83M Hold
100,513
2.16% 6
2016
Q3
$3.99M Sell
100,513
-5,682
-5% -$214K 1.69% 12
2016
Q2
$3.77M Buy
106,195
+8,370
+9% +$326K 1.68% 11
2016
Q1
$3.83M Buy
97,825
+2,214
+2% +$82.8K 2.01% 10
2015
Q4
$4.11M Sell
95,611
-6,371
-6% -$280K 2.13% 9
2015
Q3
$4.29M Buy
101,982
+17
+0% +$794 2.18% 8
2015
Q2
$5.09M Sell
101,965
-5,596
-5% -$265K 2.28% 8
2015
Q1
$4.85M Sell
107,561
-3,351
-3% -$151K 2.2% 9
2014
Q4
$5.35M Buy
110,912
+1,136
+1% +$54K 2.82% 7
2014
Q3
$5.26M Buy
109,776
+13
+0% +$631 2.88% 5
2014
Q2
$5.43M Buy
109,763
+20,097
+22% +$940K 3.08% 7
2014
Q1
$4.22M Buy
89,666
+9,729
+12% +$447K 2.48% 8
2013
Q4
$3.84M Buy
+79,937
New +$3.58M 2.57% 9

Other funds holding MET

Northeast Financial Consultants's MET Position: Q2 2025 in Review

Northeast Financial Consultants reduced its MetLife (MET) stake by 2% in Q2 2025, selling an estimated $152K and leaving 94,386 shares worth $7.59M. The position accounts for 0.31% of the portfolio, ranked #49.

Northeast Financial Consultants first reported a position in MET in Q4 2013 and has held it in 47 quarters since. The position peaked at $8.99M in Q4 2022. 1,410 funds tracked by Wall St. Rank hold MET as of Q2 2025.

  • Northeast Financial Consultants held 94,386 shares of MetLife worth $7.59M as of Q2 2025.
  • Northeast Financial Consultants sold 1,965 MetLife shares in Q2 2025, an estimated $152K.
  • MetLife made up 0.31% of Northeast Financial Consultants's portfolio in Q2 2025, its #49 holding.
  • Northeast Financial Consultants first reported a position in MetLife in Q4 2013 and has held it in 47 quarters since.
  • Northeast Financial Consultants's MetLife position peaked at $8.99M in Q4 2022.
  • 1,410 funds tracked by Wall St. Rank held MetLife as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.